NEW DELHI: The Delhi High Court Friday passed an interim order to suspended for a month the Centre’s ban on private companies producing and distributing oxytocin. The Centre had issued a notification to implement this ban from September 1.
The court was hearing pleas of Mylan Laboratories’ subsidiary BGP Products Operations GmbH, Neon Laboratories and NGO All India Drug Action Network (AIDAN).
A bench of Justices S Ravindra Bhat and A K Chawla passed an interim order on the pleas seeking to set aside the government’s ban, which was slated to come into effect from tomorrow.
The government has restricted its manufacture to the public sector only and allowed state-run Karnataka Antibiotics and Pharmaceuticals Ltd (KAPL) to produce it for domestic use.
Additional Solicitor General Maninder Acharya, appearing for the Centre, said the public sector unit had the capacity to cater to the entire nationwide demand for the drug and the government was taking the full responsibility for it.
Decision taken under Section 26A of the Drugs and Cosmetics Act 1940.
